What is wrong with Fanconi anemia cells?
- PMID: 25486020
- PMCID: PMC4614151
- DOI: 10.4161/15384101.2014.980633
What is wrong with Fanconi anemia cells?
Abstract
Figuring out what is wrong in Fanconi anemia (FA) patient cells is critical to understanding the contributions of the FA pathway to DNA repair and tumor suppression. Although FA patients exhibit a wide range of disease manifestation as well as severity (asymptomatic to congenital abnormalities, bone marrow failure, and cancer), cells from FA patients share underlying defects in their ability to process DNA lesions that interfere with DNA replication. In particular, FA cells are very sensitive to agents that induce DNA interstrand crosslinks (ICLs). The cause of this pronounced ICL sensitivity is not fully understood, but has been linked to the aberrant activation of DNA damage repair proteins, checkpoints and pathways. Thus, regulation of these responses through coordination of repair processing at stalled replication forks is an essential function of the FA pathway. Here, we briefly summarize some of the aberrant DNA damage responses contributing to defects in FA cells, and detail the newly-identified relationship between FA and the mismatch repair protein, MSH2. Understanding the contribution of MSH2 and/or other proteins to the replication problem in FA cells will be key to assessing therapeutic options to improve the health of FA patients. Moreover, loss of these factors, if linked to improved replication, could be a key event in the progression of FA cells to cancer cells. Likewise, loss of these factors could synergize to enhance tumorigenesis or confer chemoresistance in tumors defective in FA-BRCA pathway proteins and provide a basis for biomarkers for disease progression and response.
Keywords: DNA repair; FANCJ helicase; Fanconi Anemia; MSH2; crosslink repair; mismatch repair.
Figures
Similar articles
-
Crosstalk between BRCA-Fanconi anemia and mismatch repair pathways prevents MSH2-dependent aberrant DNA damage responses.EMBO J. 2014 Aug 1;33(15):1698-712. doi: 10.15252/embj.201387530. Epub 2014 Jun 25. EMBO J. 2014. PMID: 24966277 Free PMC article.
-
Functional and physical interaction between the mismatch repair and FA-BRCA pathways.Hum Mol Genet. 2011 Nov 15;20(22):4395-410. doi: 10.1093/hmg/ddr366. Epub 2011 Aug 24. Hum Mol Genet. 2011. PMID: 21865299 Free PMC article.
-
The FANCJ/MutLalpha interaction is required for correction of the cross-link response in FA-J cells.EMBO J. 2007 Jul 11;26(13):3238-49. doi: 10.1038/sj.emboj.7601754. Epub 2007 Jun 21. EMBO J. 2007. PMID: 17581638 Free PMC article.
-
Beyond interstrand crosslinks repair: contribution of FANCD2 and other Fanconi Anemia proteins to the replication of DNA.Mutat Res. 2018 Mar;808:83-92. doi: 10.1016/j.mrfmmm.2017.09.004. Epub 2017 Sep 14. Mutat Res. 2018. PMID: 29031493 Review.
-
The Fanconi anemia ID2 complex: dueling saxes at the crossroads.Cell Cycle. 2014;13(19):2999-3015. doi: 10.4161/15384101.2014.956475. Cell Cycle. 2014. PMID: 25486561 Free PMC article. Review.
Cited by
-
Mutated Fanconi anemia pathway in non-Fanconi anemia cancers.Oncotarget. 2015 Aug 21;6(24):20396-403. doi: 10.18632/oncotarget.4056. Oncotarget. 2015. PMID: 26015400 Free PMC article.
-
The Mismatch Repair System (MMR) in Head and Neck Carcinogenesis and Its Role in Modulating the Response to Immunotherapy: A Critical Review.Cancers (Basel). 2020 Oct 16;12(10):3006. doi: 10.3390/cancers12103006. Cancers (Basel). 2020. PMID: 33081243 Free PMC article. Review.
-
FANCJ at the FORK.Mutat Res. 2016 Jun;788:7-11. doi: 10.1016/j.mrfmmm.2016.02.003. Epub 2016 Feb 17. Mutat Res. 2016. PMID: 26926912 Free PMC article. Review. No abstract available.
-
Systematic analysis of DNA crosslink repair pathways during development and aging in Caenorhabditis elegans.Nucleic Acids Res. 2017 Sep 19;45(16):9467-9480. doi: 10.1093/nar/gkx660. Nucleic Acids Res. 2017. PMID: 28934497 Free PMC article.
-
Spectrin and its interacting partners in nuclear structure and function.Exp Biol Med (Maywood). 2018 Mar;243(6):507-524. doi: 10.1177/1535370218763563. Exp Biol Med (Maywood). 2018. PMID: 29557213 Free PMC article. Review.
References
-
- Walden H, Deans AJ. The Fanconi anemia DNA repair pathway: structural and functional insights into a complex disorder. Annu Rev Biophys 2014; 43:257-78; PMID:24773018; http://dx.doi.org/10.1146/annurev-biophys-051013-022737. - DOI - PubMed
-
- Nalepa G, Clapp DW. Fanconi anemia and the cell cycle: new perspectives on aneuploidy. F1000Prime Rep 2014; 6:23; PMID:24765528; http://dx.doi.org/10.12703/P6-23 - DOI - PMC - PubMed
-
- Ceccaldi R, Parmar K, Mouly E, Delord M, Kim JM, Regairaz M, Pla M, Vasquez N, Zhang QS, Pondarre C, et al. . Bone marrow failure in fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells. Cell Stem Cell 2012; 11:36-49; PMID:22683204; http://dx.doi.org/10.1016/j.stem.2012.05.013 - DOI - PMC - PubMed
-
- Pang Q, Andreassen PR. Fanconi anemia proteins and endogenous stresses. Mutat Res 2009; 668:42-53; PMID:19774700; http://dx.doi.org/10.1016/j.mrfmmm.2009.03.013 - DOI - PMC - PubMed
-
- Zhang J, Walter JC. Mechanism and regulation of incisions during DNA interstrand cross-link repair. DNA Repair 2014; 19:135-42; PMID:24768452; http://dx.doi.org/10.1016/j.dnarep.2014.03.018 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous